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anomalies, and suggest potential therapeutic approaches to adult
heart disease.
doi:10.1016/j.ydbio.2011.05.369
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Introduction: We have recently shown that excessive transforming
grow factor (TGF-β) signaling mediates hypoxia-induces inhibition of
alveolar development and abnormal pulmonary arterial remodeling
in the newborn lung, producing a phenotype that mimics broncho-
pulmonary dysplasia (BPD) in preterm infants. The mechanisms by
which excessive TGF-β signaling inhibits alveolar septation are not
known. Fibroblast growth factor (FGF)-10 is a critical modulator of
early lung development and in the saccular stage but its role in
alveolar septation has not been defined. It has been shown that the
FGF-10 promoter contains a TGF-β response element. Objective: We
hypothesized that excessive TGF-β signaling in the newborn hypoxia-
induced mouse lung inhibits alveolar septation via reduction of FGF-
10. Methods: In vivo: Wilde type C57BL/6 were exposed to air or
hypoxia (12% O2) from birth to two weeks (the critical period of lung
development) and evaluated for FGF-10 and TGF-β mRNA and
protein. Inhibition of TGF-β signaling was achieved by administration
of TGF-β neutralizing antibody (ID11) to WT mice or 20 ug/g ZnSO4
given intraperitoneally daily to DNIIR pups (an inducible dominant-
negative mutation of the TGF-β type II receptor) and exposed to
hypoxia or air from birth to 14 days of age. In vitro: Newborn Lung
Fibroblasts and Pulmonary Microvascular Endothelial Cells (PMVEC)
were exposed to air or hypoxia for 24 h. FGF-10 mRNA and protein
were evaluated in cell lysates. Results: Hypoxia reduces FGF-10 mRNA
in both in vivo (Fig. 1) and in vitro studies (Fig. 3). Pups receiving the
TGF-β neutralizing antibody (ID11) had increased FGF-10 and better
lung development (Fig. 1). FGF-10 staining was not significantly
decreased in DNIIR hypoxic mice compared to air control (Fig. 2).
Conclusion: These results suggest that hypoxia-induced increased
TGF-β signaling may reduce FGF-10, which may contribute to
impairment of lung development. Future experiments: Additional
studies are in progress to inhibit FGF-10 signaling in vivo, to
determine if FGF-10 is necessary for alveolar septation.
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Juvenile hydrocephalus, the accumulation of cerebrospinal fluid
(CSF) in the ventricles of the brain, causes significant morbidity
among human children affecting roughly 1 in 500 newborns. The
disease manifests due to overproduction, decreased absorption, or
restricted flow of CSF. Few genetic causes of this disease are known,
and therefore animal models can prove beneficial in identifying
candidate genes. The Juvenile hydrocephalus (Jh) mouse line contains
a transgenic integration on mouse chromosome 9. Homozygous Jh
mice exhibit hydrocephalus by two weeks of age and few survive
beyond eight weeks. This phenotype represents a novel cause of the
disease since no known hydrocephalus mutations map to the region.
Analysis of the integration site showed disruption of an uncharacter-
ized gene, I11. Preliminary data suggests that a transgene carrying a
functional copy of I11 can rescue the Jh phenotype. However, the
predicted protein product of I11 has no recognizable functional
domains and its role in CSF maintenance is unknown. Future research
will focus on definitively establishing the role of I11 in hydrocephalus
and dissecting its function.
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Purpose: Peters-Plus Syndrome (PPS) is an autosomal recessive
disorder characterized by ocular anterior segment dysgenesis
(primarily Peters' anomaly), short stature and brachydactyly along
with additional variable features. Mutations in Beta-1,3-glucosyl-
transferase (B3GALTL) gene were shown to explain 100% of classic
PPS cases. No animal models have yet been developed. This study
aims to characterize zebrafish orthologues of B3GALTL in terms of
sequence, expression pattern and function. Methods: Zebrafish
orthologues of human B3GALTL were identified using database
analysis, RT-PCR and sequencing; expression was analyzed using
RT-PCR and in situ hybridization; knockdown was performed via
injection of morpholino oligomers targeting zebrafish B3GALTL genes
followed by RT-PCR transcript analyses. Gross morphological analysis
of morphants was done using alcian blue staining and histology.
Results: Two orthologues of human B3GALTL gene were identified:
B3GALTLA and B3GALTLB. Each is expressed early in development. In
situ hybridization showed distinct expression patterns for B3GALTLA
in the brain, lens, retina, and other structures. Knockdown of one or
both genes produced zebrafish with phenotypes similar to PPS. Alcian
blue staining revealed defects in craniofacial cartilage formation.
Histology and brightfield examination showed cornea and brain
malformations, curved and short trunks, enlarged heart, and fin
abnormalities. Semi-quantitative RT-PCR data confirmed morpholino
efficiency. Conclusion: Zebrafish B3GALTLA and B3GALTLB are essen-
tial for normal embryonic development and have conserved function
with the human gene. A zebrafish model of PPS is being developed to
study mechanisms of this debilitating condition.
doi:10.1016/j.ydbio.2011.05.372
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Schistosomiasis is a tropical disease caused by flatworm parasites
(Schistosoma) that affects hundreds of millions of people in the
developing world. Although only a single drug (praziquantel) is
available to treat this disease, the complicated life cycle of this
parasite, that involves both mollusc and vertebrate hosts, impedes
efforts to uncover and validate novel therapeutic targets. Thus, we are
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